SELENBP1 and breast cancer: SELENBP1 can also interact with the retinoid-receptor RARα in the nuclear material, whose interaction is reduced by all trans-retinoic acid (ATRA, a cancer drug) in the breast cancer cell line (Gianni et al., 2019).